Evidence map›Paper›PMID 40290644›Full record

ReviewPreventive medicine reports2025

HIV pre-exposure prophylaxis in Latin America: Public policies, healthcare systems and human rights.

Herta de Oliveira Alexandre, Sofia Gruskin, Adriano Massuda, Maria Rita Bertolozzi, Aluisio Cotrim Segurado

Abstract readReview
In one paragraph

Review in Preventive medicine reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Herta de Oliveira AlexandreFaculdade de Medicina, Universidade de São Paulo, Av. Dr. Eneas de Carvalho Aguiar 470, 05403-000 São Paulo, SP, Brazil.
Sofia GruskinInstitute on Inequalities in Global Health, University of Southern California, 1845 N. Soto St., Los Angeles, CA 90032, USA.
Adriano MassudaGetulio Vargas Foundation, Av. Nove de Julho 2029, 01313-902 São Paulo, SP, Brazil.
Maria Rita BertolozziEscola de Enfermagem, Universidade de São Paulo, Av. Dr. Eneas de Carvalho Aguiar, 419, 05403-000 São Paulo, SP, Brazil.
Aluisio Cotrim SeguradoFaculdade de Medicina, Universidade de São Paulo, Av. Dr. Eneas de Carvalho Aguiar 470, 05403-000 São Paulo, SP, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: In concentrated HIV epidemics, combination prevention is recommended for key populations, including pre-exposure prophylaxis (PrEP). Our study analyzes PrEP's integration as a public policy in Spanish, Portuguese and French-speaking Latin American countries. Methods: We reviewed documents published through December 2024 from Ministries of Health, international organizations, relevant non-governmental organizations, and collected data on countries' human development index (HDI), healthcare system organization/expenditures, assessing compliance with human rights standards. Results: PrEP policies are described in 16 out of 20 countries reviewed. In Argentina, Brazil, Chile, Colombia, Cuba, El Salvador, Haiti, Mexico and Peru, PrEP is provided to key populations. In Costa Rica, Guatemala, Panama and Paraguay, PrEP is available through research or pilot projects. In the Dominican Republic, Ecuador, and Honduras, PrEP is being scaled up, but specifics remain unclear. Other countries have limited access to PrEP or no available information. Broad PrEP distribution occurs generally in countries with higher healthcare expenditures relative to gross domestic product and high HDI. However, its distribution free of charge is not correlated with universal access to public healthcare. Attention to human rights standards was noted in policies from Argentina, Brazil, Chile, Cuba, Ecuador, El Salvador, Haiti, Mexico, Peru and Uruguay, covering rights to healthcare access, information, informed decision-making, participation, equality, privacy, accountability, and benefits of scientific progress. Conclusions: As of December 2024, PrEP policies exist in some Latin American countries, but are limited or unavailable in others. Achieving universal healthcare and adhering to human rights norms can improve access/use of this essential HIV prevention tool.

Indexed as

Healthcare expendituresHealthcare systemsHIVHuman rightsLatin AmericaPre-exposure prophylaxis

Identifiers

PMID40290644
PMCPMC12023865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.